Antipsychotic Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Antipsychotic stocks.

Antipsychotic Stocks Recent News

Date Stock Title
May 23 JNJ ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
May 23 JNJ Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23 JNJ ASCO24: An early look at cancer drug study results
May 23 JNJ Johnson & Johnson: Vital Signs Decent, A Compelling Value Case
May 23 JNJ J&J faces lawsuit over talc-related bankruptcy filings
May 22 JNJ Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
May 22 JNJ Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies
May 22 JNJ Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American
May 22 JNJ J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
May 21 JNJ Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
May 21 JNJ J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
May 20 JNJ Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis
May 20 JNJ Pulsed field ablation poised for fast adoption, analysts say
May 20 JNJ J&J posts latest Varipulse data while awaiting FDA review
May 19 JNJ Biopharma M&A surges year over year in Q1
May 18 JNJ Novo Nordisk, J&J lead R&D rankings in big pharma: report
May 18 JNJ Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18 JNJ Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO
May 17 JNJ Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
May 17 JNJ J&J-backed startup Rapport files for US IPO
Antipsychotic

Antipsychotics, also known as neuroleptics, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder.The use of antipsychotics may result in many unwanted side effects such as involuntary movement disorders, gynecomastia, impotence, weight gain and metabolic syndrome. Long-term use can produce adverse effects such as tardive dyskinesia.
First-generation antipsychotics, known as typical antipsychotics, were first introduced in the 1950s, and others were developed until the early 1970s. Second-generation drugs, known as atypical antipsychotics, were introduced firstly with clozapine in the early 1970s followed by others. Both generations of medication block receptors in the brain for dopamine, but atypicals tend to act on serotonin receptors as well. Neuroleptic, originating from Greek: νεῦρον (neuron) and λαμβάνω (take hold of)—thus meaning "which takes the nerve"—refers to both common neurological effects and side effects.

Browse All Tags